Comparison of the safety of two treatment methods of cesarean scar pregnancy of type Ⅱ and Ⅲ in menopause within 7 weeks
10.3760/cma.j.issn.0529-567x.2017.07.004
- VernacularTitle:停经7周以内的Ⅱ型和Ⅲ型剖宫产术后子宫瘢痕妊娠两种治疗方法的安全性比较
- Author:
Xiaoyu WEI
;
Xiaolan YU
- Keywords:
Cesarean section;
Pregnancy;
ectopic;
Methotrexate;
Uterine artery embolization;
Curettage
- From:
Chinese Journal of Obstetrics and Gynecology
2017;52(7):449-454
- CountryChina
- Language:Chinese
-
Abstract:
Objective To comparison of the safety of two treatment methods of cesarean scar pregnancy (CSP) of typeⅡ and Ⅲ in menopause within 7 weeks. Methods Totally 70 cases of CSP of typeⅡ and Ⅲ within 7 weeks of the last menstrual period, hospitalized within Peking University First Hospital from January 2009 to May 2016, had been retrospectively studied in two groups of different treatments. The methotrexate (MTX) treatment group included 37 cases receiving ultrasound-guided complete curettage of uterine cavity combined with MTX therapy, while the uterine artery embolization (UAE) group had 33 cases treated with UAE combined with MTX therapy and subsequent ultrasound-guided complete curettage of uterine cavity. The bleeding measurements during operation had been documented and compared for the study. Results The comparative difference of bleeding measurements between the MTX treatment group and the UAE group was insignificant from the statistical perspective (median: 5.0 vs 5.0 ml, P=0.716).The comparative difference of the duration (median: 2.0 vs 6.0 days, P<0.01) and expenses (median: 2832.1 vs 10147.1 yuan, P<0.01) for hospitalization between the MTX treatment group and the UAE group were significant from the statistical perspective. Conclusions The bleeding risks may not increase during the treatment of ultrasound-guided complete curettage of uterine cavity combined with MTX therapy for CSP patients of type Ⅱ and Ⅲwithin 7 weeks of the last menstrual period. Meanwhile, the UAE adverse effects and complications will be avoided, and the duration and expenses for hospitalization will be reduced.
